Covered recipient · General Payments record
CARLA J ROSAL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,512.65
- Reported across 269 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $834.83 | 51 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $287.15 | 25 |
| GlaxoSmithKline, LLC. | $109.05 | 5 |
| Lilly USA, LLC | $96.84 | 4 |
| PFIZER INC. | $92.55 | 5 |
| Mylan Specialty L.P. | $67.21 | 2 |
| Novo Nordisk AS | $46.88 | 2 |
| Amgen Inc. | $27.98 | 2 |
| ABIOMED | $24.19 | 1 |
| Philips Electronics North America Corporation | $21.58 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.66 | 1 |
| Acerta Pharma LLC | $14.86 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (51)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.54 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972176 | CMS |
| ABBVIE INC. | $13.73 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972178 | CMS |
| ABBVIE INC. | $15.88 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972180 | CMS |
| ABBVIE INC. | $2.88 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972182 | CMS |
| ABBVIE INC. | $25.63 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972184 | CMS |
| ABBVIE INC. | $5.91 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972186 | CMS |
| ABBVIE INC. | $13.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972188 | CMS |
| ABBVIE INC. | $11.55 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972190 | CMS |
| ABBVIE INC. | $20.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972192 | CMS |
| ABBVIE INC. | $10.96 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972194 | CMS |
| ABBVIE INC. | $13.55 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972196 | CMS |
| ABBVIE INC. | $13.61 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972198 | CMS |
| ABBVIE INC. | $32.75 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972200 | CMS |
| ABBVIE INC. | $1.62 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972202 | CMS |
| ABBVIE INC. | $11.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972204 | CMS |
| ABBVIE INC. | $26.98 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972206 | CMS |
| ABBVIE INC. | $8.23 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972208 | CMS |
| ABBVIE INC. | $1.87 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972210 | CMS |
| ABBVIE INC. | $9.52 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972212 | CMS |
| ABBVIE INC. | $11.11 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972214 | CMS |
| ABBVIE INC. | $0.89 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972216 | CMS |
| ABBVIE INC. | $11.21 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972218 | CMS |
| ABBVIE INC. | $1.85 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972220 | CMS |
| ABBVIE INC. | $4.03 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972222 | CMS |
| ABBVIE INC. | $5.52 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105972224 | CMS |
| ABIOMED | $24.19 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142302239 | CMS |
| Amgen Inc. | $14.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117368937 | CMS |
| Amgen Inc. | $13.98 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117368939 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.86 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105844981 | CMS |
| GlaxoSmithKline, LLC. | $15.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116619541 | CMS |
| GlaxoSmithKline, LLC. | $25.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115915301 | CMS |
| GlaxoSmithKline, LLC. | $23.00 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116712397 | CMS |
| GlaxoSmithKline, LLC. | $16.28 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116230685 | CMS |
| GlaxoSmithKline, LLC. | $28.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116716623 | CMS |
| Lilly USA, LLC | $24.04 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136091374 | CMS |
| Lilly USA, LLC | $24.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136085702 | CMS |
| Lilly USA, LLC | $33.36 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136088720 | CMS |
| Lilly USA, LLC | $14.64 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136088722 | CMS |
| Mylan Specialty L.P. | $32.54 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147301599 | CMS |
| Mylan Specialty L.P. | $34.67 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147323257 | CMS |
| Novo Nordisk Inc | $26.78 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096568354 | CMS |
| Novo Nordisk Inc | $20.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097337513 | CMS |
| PFIZER INC. | $18.80 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131129227 | CMS |
| PFIZER INC. | $20.73 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033151 | CMS |
| PFIZER INC. | $18.25 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131681267 | CMS |
| PFIZER INC. | $14.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132117300 | CMS |
| PFIZER INC. | $20.32 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205393 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.66 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151117611 | CMS |
| Philips North America LLC | $21.58 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146919000 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137664178 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.67 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144589594 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.